PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148924
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148924
Blood Screening Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of blood screening Market
The global blood screening market size was valued at USD 3.56 billion in 2025 and is projected to grow from USD 3.90 billion in 2026 to USD 8.20 billion by 2034, exhibiting a CAGR of 9.73% during the forecast period. North America dominated the global market with a 41.86% share in 2025. The market is gaining momentum due to increasing blood donations, growing awareness of transfusion safety, rising infectious diseases, and government initiatives aimed at improving the safety of donated blood.
Blood screening tests are designed to identify markers of transfusion-transmissible infections (TTIs) and help ensure the safety of donated blood units. The increasing adoption of automated molecular platforms is further improving screening accuracy and reducing manual errors in blood banks, hospitals, and laboratories.
Market Definition and Scope
Blood screening includes diagnostic testing of donated blood to identify infectious disease markers and other risks that could affect transfusion safety. Technologies used in the market include molecular tests and serology tests, while products are broadly divided into reagents & kits and instruments.
The market is analyzed across product type, technology, end user, and geographical regions. Increasing blood transfusion procedures and improvements in laboratory infrastructure are expected to support the market through 2034.
Blood Screening Market Trends
Introduction of Automated Molecular Platforms
The transition from manual to automated blood screening platforms is one of the major market trends. Automated systems can improve testing efficiency, reduce human error, and support rapid detection of infectious diseases.
Molecular technologies, particularly nucleic acid testing (NAT), provide high sensitivity for detecting viral nucleic acids. The introduction of advanced automated platforms by leading diagnostic companies is encouraging their adoption across blood donation centers and clinical laboratories.
Blood Screening Market Growth Factors
Increasing Number of Blood Donations
The growing number of blood donations and donors is creating consistent demand for screening procedures. Government organizations, healthcare institutions, and nonprofit organizations are increasing awareness regarding voluntary blood donation and transfusion safety.
Growing demand for blood in accident treatment, cancer care, surgeries, and other medical procedures is also increasing the importance of screening. As blood utilization increases, healthcare providers require reliable testing procedures to minimize the risk of transfusion-transmitted infections.
Rising Prevalence of Infectious Diseases
The continued prevalence of infections such as HIV, hepatitis B, hepatitis C, syphilis, and other transfusion-transmissible diseases is encouraging healthcare systems to strengthen blood screening practices. Greater awareness of blood safety and improvements in diagnostic technologies are further supporting market adoption.
Restraining Factors
High Instrument Costs and Inadequate Infrastructure
High costs associated with advanced blood screening instruments can restrict adoption, particularly in emerging economies. Several developing markets continue to face limitations in healthcare infrastructure, laboratory capacity, trained personnel, and investment in advanced screening technologies.
Stringent regulatory requirements and the need for sophisticated testing facilities can further increase the cost of blood screening programs and limit market penetration in underdeveloped healthcare systems.
Blood Screening Market Segmentation Analysis
By Product Type
The reagents & kits segment is expected to maintain its leading position, accounting for 83.5% of the market in 2025. These products are consumed in large volumes for repeated blood screening procedures and are generally more affordable than screening instruments.
The instruments segment is expected to grow at a comparatively slower pace because instruments are reusable and have longer operating lifecycles. However, automation and technological improvements are expected to support demand for advanced instruments.
By Technology
The market is divided into molecular tests and serology tests. Molecular testing is supported by the high sensitivity of NAT for detecting viral nucleic acids and enabling early identification of infections such as HIV, HBV, and HCV.
Serology testing remains important because techniques such as ELISA and chemiluminescence immunoassay provide cost-effective options, particularly in emerging markets.
By End User
End users include independent clinical laboratories and hospital-based laboratories. Hospital-based laboratories are expected to gain importance through 2026 because of increasing blood transfusion procedures and the implementation of patient blood management programs.
Regional Blood Screening Market Analysis
North America
North America remains the leading regional market, supported by a large donor population, high awareness of blood safety, advanced healthcare infrastructure, and widespread adoption of screening technologies. The region accounted for 41.86% of the global market in 2025.
Europe
Europe is expected to witness steady growth, supported by advanced healthcare systems and increasing adoption of modern blood screening technologies. The region is projected to register a 7.3% CAGR during the forecast period.
Asia Pacific
Asia Pacific is expected to record significant growth as healthcare investments increase and diagnostic infrastructure improves. China and India represent important opportunities due to their large populations, increasing patient affordability, and rising healthcare requirements.
U.S. and Japan
The U.S. market is expected to grow steadily because of advanced laboratory infrastructure and high demand for safe blood products. The Japan blood screening market is expected to reach USD 208.2 million in 2025, supported by its established healthcare and diagnostic systems.
Competitive Landscape
The competitive landscape includes companies focusing on automated platforms, molecular diagnostics, product launches, acquisitions, and technological innovation. Major companies include Bio-Rad Laboratories, Grifols, F. Hoffmann-La Roche, Ortho Clinical Diagnostics, BD, DiaSorin, Thermo Fisher Scientific, Abbott, and QUOTIENT.
Key Industry Developments
Leading companies have continued introducing advanced blood screening and molecular diagnostic technologies. Grifols expanded its NAT capabilities through the acquisition of a manufacturing facility, while other diagnostic companies have introduced automated platforms and blood-based testing technologies for infectious diseases and broader screening applications.
Future Outlook
The blood screening market outlook remains positive as healthcare systems increasingly prioritize transfusion safety and automated diagnostics. Growing blood donation volumes, rising infectious disease concerns, technological advances in molecular testing, and expansion of hospital laboratory infrastructure are expected to support market growth through 2034.
Report Coverage
The blood screening market report provides detailed Market Analysis covering market size, market value, product types, technologies, end users, regional performance, market trends, growth factors, restraints, competitive landscape, and key industry developments. It also examines the adoption of automated screening platforms, molecular testing technologies, laboratory infrastructure, and strategies adopted by leading companies.
Conclusion
The global blood screening market is projected to expand from USD 3.56 billion in 2025 to USD 3.90 billion in 2026 and USD 8.20 billion by 2034. Increasing blood donations, greater awareness of transfusion safety, infectious disease prevalence, and the adoption of automated molecular screening platforms will remain major growth drivers. Reagents & kits and molecular testing are expected to remain important market segments, while improvements in healthcare infrastructure and advanced diagnostic technologies will create further opportunities across emerging and developed markets.
Unit Value (USD billion)
Segmentation By Product Type
- Instruments
- Reagents & Kits
By Technology
- Molecular Tests
- Serology Tests
By End User
- Independent Clinical Laboratories
- Hospital-based Laboratories
- Others
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Technology Advances, Blood Screening Techniques
- 4.2. Key Developments: Mergers, Partnerships, New Product Launches, etc.
- 4.3. Number of Blood Donations: Key Countries, 2025
- 4.4. Regulatory Scenario, Key Regions
- 4.5. Overview: Government Initiatives Towards Blood Donations
5. Global Blood Screening Market Analysis, Insights and Forecast, 2025-2034
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast - By Product Type
- 5.2.1. Instruments
- 5.2.2. Reagents & Kits
- 5.3. Market Analysis, Insights and Forecast - By Technology
- 5.3.1. Molecular Tests
- 5.3.2. Serology Tests
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Independent Clinical Laboratories
- 5.4.2. Hospital-based Laboratories
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By Country
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Blood Screening Market Analysis, Insights and Forecast, 2025-2034
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast - By Product Type
- 6.2.1. Instruments
- 6.2.2. Reagents & Kits
- 6.3. Market Analysis, Insights and Forecast - By Technology
- 6.3.1. Molecular Tests
- 6.3.2. Serology Tests
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Independent Clinical Laboratories
- 6.4.2. Hospital-based Laboratories
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Blood Screening Market Analysis, Insights and Forecast, 2025-2034
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast - By Product Type
- 7.2.1. Instruments
- 7.2.2. Reagents & Kits
- 7.3. Market Analysis, Insights and Forecast - By Technology
- 7.3.1. Molecular Tests
- 7.3.2. Serology Tests
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Independent Clinical Laboratories
- 7.4.2. Hospital-based Laboratories
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Blood Screening Market Analysis, Insights and Forecast, 2025-2034
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast - By Product Type
- 8.2.1. Instruments
- 8.2.2. Reagents & Kits
- 8.3. Market Analysis, Insights and Forecast - By Technology
- 8.3.1. Molecular Tests
- 8.3.2. Serology Tests
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Independent Clinical Laboratories
- 8.4.2. Hospital-based Laboratories
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Blood Screening Market Analysis, Insights and Forecast, 2025-2034
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast - By Product Type
- 9.2.1. Instruments
- 9.2.2. Reagents & Kits
- 9.3. Market Analysis, Insights and Forecast - By Technology
- 9.3.1. Molecular Tests
- 9.3.2. Serology Tests
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Independent Clinical Laboratories
- 9.4.2. Hospital-based Laboratories
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Blood Screening Market Analysis, Insights and Forecast, 2025-2034
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast - By Product Type
- 10.2.1. Instruments
- 10.2.2. Reagents & Kits
- 10.3. Market Analysis, Insights and Forecast - By Technology
- 10.3.1. Molecular Tests
- 10.3.2. Serology Tests
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Independent Clinical Laboratories
- 10.4.2. Hospital-based Laboratories
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2025)
- 11.3. Company Profiles
- 11.3.1. Bio-Rad Laboratories, Inc
- 11.3.1.1. Overview,
- 11.3.1.2. Products,
- 11.3.1.3. SWO,
- 11.3.1.4. Recent Developments,
- 11.3.1.5. Strategies,
- 11.3.1.6. Financials (based on availability)
- 11.3.2. Grifols, S.A.
- 11.3.2.1. Overview,
- 11.3.2.2. Products,
- 11.3.2.3. SWO,
- 11.3.2.4. Recent Developments,
- 11.3.2.5. Strategies,
- 11.3.2.6. Financials (based on availability)
- 11.3.3. F. Hoffmann-La Roche
- 11.3.3.1. Overview,
- 11.3.3.2. Products,
- 11.3.3.3. SWO,
- 11.3.3.4. Recent Developments,
- 11.3.3.5. Strategies,
- 11.3.3.6. Financials (based on availability)
- 11.3.4. Ortho Clinical Diagnostics
- 11.3.4.1. Overview,
- 11.3.4.2. Products,
- 11.3.4.3. SWO,
- 11.3.4.4. Recent Developments,
- 11.3.4.5. Strategies,
- 11.3.4.6. Financials (based on availability)
- 11.3.5. DiaSorin S.p.A.
- 11.3.5.1. Overview,
- 11.3.5.2. Products,
- 11.3.5.3. SWO,
- 11.3.5.4. Recent Developments,
- 11.3.5.5. Strategies,
- 11.3.5.6. Financials (based on availability)
- 11.3.6. BD
- 11.3.6.1. Overview,
- 11.3.6.2. Products,
- 11.3.6.3. SWO,
- 11.3.6.4. Recent Developments,
- 11.3.6.5. Strategies,
- 11.3.6.6. Financials (based on availability)
- 11.3.7. Thermo Fisher Scientific Inc.
- 11.3.7.1. Overview,
- 11.3.7.2. Products,
- 11.3.7.3. SWO,
- 11.3.7.4. Recent Developments,
- 11.3.7.5. Strategies,
- 11.3.7.6. Financials (based on availability)
- 11.3.8. Abbott
- 11.3.8.1. Overview,
- 11.3.8.2. Products,
- 11.3.8.3. SWO,
- 11.3.8.4. Recent Developments,
- 11.3.8.5. Strategies,
- 11.3.8.6. Financials (based on availability)
- 11.3.9. Quotient
- 11.3.9.1. Overview,
- 11.3.9.2. Products,
- 11.3.9.3. SWO,
- 11.3.9.4. Recent Developments,
- 11.3.9.5. Strategies,
- 11.3.9.6. Financials (based on availability)
- 11.3.10. Other Players
- 11.3.10.1. Overview,
- 11.3.10.2. Products,
- 11.3.10.3. SWO,
- 11.3.10.4. Recent Developments,
- 11.3.10.5. Strategies,
- 11.3.10.6. Financials (based on availability)
- 11.3.1. Bio-Rad Laboratories, Inc
12. Strategic Recommendations
List of Tables
- Table 1: Global Blood Screening Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
- Table 2: Global Blood Screening Market Revenue (US$ Mn) Forecast, by Technology, 2021-2034
- Table 3: Global Blood Screening Market Revenue (US$ Mn) Forecast, by Modality, 2021-2034
- Table 4: Global Blood Screening Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 5: Global Blood Screening Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
- Table 6: North America Blood Screening Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
- Table 7: North America Blood Screening Market Revenue (US$ Mn) Forecast, by Technology, 2021-2034
- Table 8: North America Blood Screening Market Revenue (US$ Mn) Forecast, by Modality, 2021-2034
- Table 9: North America Blood Screening Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 10: North America Blood Screening Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
- Table 11: Europe Blood Screening Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
- Table 12: Europe Blood Screening Market Revenue (US$ Mn) Forecast, by Technology, 2021-2034
- Table 13: Europe Blood Screening Market Revenue (US$ Mn) Forecast, by Modality, 2021-2034
- Table 14: Europe Blood Screening Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 15: Europe Blood Screening Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 16: Asia Pacific Blood Screening Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
- Table 17: Asia Pacific Blood Screening Market Revenue (US$ Mn) Forecast, by Technology, 2021-2034
- Table 18: Asia Pacific Blood Screening Market Revenue (US$ Mn) Forecast, by Modality, 2021-2034
- Table 19: Asia Pacific Blood Screening Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 20: Asia Pacific Blood Screening Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Latin America Blood Screening Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
- Table 22: Latin America Blood Screening Market Revenue (US$ Mn) Forecast, by Technology, 2021-2034
- Table 23: Latin America Blood Screening Market Revenue (US$ Mn) Forecast, by Modality, 2021-2034
- Table 24: Latin America Blood Screening Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 25: Latin America Blood Screening Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: Middle East & Africa Blood Screening Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
- Table 27: Middle East & Africa Blood Screening Market Revenue (US$ Mn) Forecast, by Technology, 2021-2034
- Table 28: Middle East & Africa Blood Screening Market Revenue (US$ Mn) Forecast, by Modality, 2021-2034
- Table 29: Middle East & Africa Blood Screening Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
- Table 30: Middle East & Africa Blood Screening Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Blood Screening Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034
- Figure 2: Global Blood Screening Market Value Share (%), by Product Type, 2025 & 2034
- Figure 3: Global Blood Screening Market Forecast (US$ Mn), by Instruments, 2025-2034
- Figure 4: Global Blood Screening Market Forecast (US$ Mn), by Reagents & Kits, 2025-2034
- Figure 5: Global Blood Screening Market Value Share (%), by Technology, 2025 & 2034
- Figure 6: Global Blood Screening Market Forecast (US$ Mn), by Molecular Tests, 2025-2034
- Figure 7: Global Blood Screening Market Forecast (US$ Mn), by Serology Tests, 2025-2034
- Figure 8: Global Blood Screening Market Value Share (%), by End-user, 2025 & 2034
- Figure 9: Global Blood Screening Market Forecast (US$ Mn), by Independent Clinical Laboratories, 2025-2034
- Figure 10: Global Blood Screening Market Forecast (US$ Mn), by Hospital-based Laboratories, 2025-2034
- Figure 11: Global Blood Screening Market Forecast (US$ Mn), by Others, 2025-2034
- Figure 12: Global Blood Screening Market Value (US$ Mn), by Region, 2025 & 2034
- Figure 13: North America Blood Screening Market Value (US$ Mn), by Product Type, 2025 & 2034
- Figure 14: North America Blood Screening Market Value Share (%), by Product Type, 2025
- Figure 15: North America Blood Screening Market Value (US$ Mn), by Technology, 2025 & 2034
- Figure 16: North America Blood Screening Market Value Share (%), by Technology, 2025
- Figure 17: North America Blood Screening Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 18: North America Blood Screening Market Value Share (%), by End-user, 2025
- Figure 19: North America Blood Screening Market Value (US$ Mn), By Country, 2025 & 2034
- Figure 20: North America Blood Screening Market Value Share (%), By Country, 2025
- Figure 21: Europe Blood Screening Market Value (US$ Mn), by Product Type, 2025 & 2034
- Figure 22: Europe Blood Screening Market Value Share (%), by Product Type, 2025
- Figure 23: Europe Blood Screening Market Value (US$ Mn), by Technology, 2025 & 2034
- Figure 24: Europe Blood Screening Market Value Share (%), by Technology, 2025
- Figure 25: Europe Blood Screening Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 26: Europe Blood Screening Market Value Share (%), by End-user, 2025
- Figure 27: Europe Blood Screening Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 28: Europe Blood Screening Market Value Share (%), By Country/ Sub-region, 2025
- Figure 29: Asia Pacific Blood Screening Market Value (US$ Mn), by Product Type, 2025 & 2034
- Figure 30: Asia Pacific Blood Screening Market Value Share (%), by Product Type, 2025
- Figure 31: Asia Pacific Blood Screening Market Value (US$ Mn), by Technology, 2025 & 2034
- Figure 32: Asia Pacific Blood Screening Market Value Share (%), by Technology, 2025
- Figure 33: Asia Pacific Blood Screening Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 34: Asia Pacific Blood Screening Market Value Share (%), by End-user, 2025
- Figure 35: Asia Pacific Blood Screening Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 36: Asia Pacific Blood Screening Market Value Share (%), By Country/ Sub-region, 2025
- Figure 37: Latin America Blood Screening Market Value (US$ Mn), by Product Type, 2025 & 2034
- Figure 38: Latin America Blood Screening Market Value Share (%), by Product Type, 2025
- Figure 39: Latin America Blood Screening Market Value (US$ Mn), by Technology, 2025 & 2034
- Figure 40: Latin America Blood Screening Market Value Share (%), by Technology, 2025
- Figure 41: Latin America Blood Screening Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 42: Latin America Blood Screening Market Value Share (%), by End-user, 2025
- Figure 43: Latin America Blood Screening Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 44: Latin America Blood Screening Market Value Share (%), By Country/ Sub-region, 2025
- Figure 45: Middle East & Africa Blood Screening Market Value (US$ Mn), by Product Type, 2025 & 2034
- Figure 46: Middle East & Africa Blood Screening Market Value Share (%), by Product Type, 2025
- Figure 47: Middle East & Africa Blood Screening Market Value (US$ Mn), by Technology, 2025 & 2034
- Figure 48: Middle East & Africa Blood Screening Market Value Share (%), by Technology, 2025
- Figure 49: Middle East & Africa Blood Screening Market Value (US$ Mn), by End-user, 2025 & 2034
- Figure 50: Middle East & Africa Blood Screening Market Value Share (%), by End-user, 2025
- Figure 51: Middle East & Africa Blood Screening Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
- Figure 52: Middle East & Africa Blood Screening Market Value Share (%), By Country/ Sub-region, 2025
- Figure 53: Global Blood Screening Market Share (%), By Company, 2025
